These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 10502824)
21. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896 [TBL] [Abstract][Full Text] [Related]
22. Life without neuropeptide Y. Palmiter RD; Erickson JC; Hollopeter G; Baraban SC; Schwartz MW Recent Prog Horm Res; 1998; 53():163-99. PubMed ID: 9769708 [TBL] [Abstract][Full Text] [Related]
23. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA. Modin A; Malmström RE; Meister B Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500 [TBL] [Abstract][Full Text] [Related]
25. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption. Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983 [TBL] [Abstract][Full Text] [Related]
26. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice. Lin EJ; Young D; Baer K; Herzog H; During MJ Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144 [TBL] [Abstract][Full Text] [Related]
27. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Marsh DJ; Hollopeter G; Kafer KE; Palmiter RD Nat Med; 1998 Jun; 4(6):718-21. PubMed ID: 9623983 [TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855 [TBL] [Abstract][Full Text] [Related]
29. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice. Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383 [TBL] [Abstract][Full Text] [Related]
31. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311 [TBL] [Abstract][Full Text] [Related]
32. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms. Gao J; Ghibaudi L; Hwa JJ Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E706-11. PubMed ID: 15187000 [TBL] [Abstract][Full Text] [Related]
33. Introduction to the reviews on neuropeptide Y. Gehlert DR Neuropeptides; 2004 Aug; 38(4):135-40. PubMed ID: 15337366 [TBL] [Abstract][Full Text] [Related]
34. Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. Stanić D; Brumovsky P; Fetissov S; Shuster S; Herzog H; Hökfelt T J Comp Neurol; 2006 Nov; 499(3):357-90. PubMed ID: 16998904 [TBL] [Abstract][Full Text] [Related]
35. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5. Berglund MM; Saar K; Lundell I; Langel U; Larhammar D Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204 [TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity. Tu B; Jiao Y; Herzog H; Nadler JV Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162 [TBL] [Abstract][Full Text] [Related]
37. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. Mashiko S; Moriya R; Ishihara A; Gomori A; Matsushita H; Egashira S; Iwaasa H; Takahashi T; Haga Y; Fukami T; Kanatani A Eur J Pharmacol; 2009 Aug; 615(1-3):113-7. PubMed ID: 19482021 [TBL] [Abstract][Full Text] [Related]
38. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H J Bone Miner Res; 2006 Oct; 21(10):1600-7. PubMed ID: 16995815 [TBL] [Abstract][Full Text] [Related]
39. NPY and Y receptors: lessons from transgenic and knockout models. Lin S; Boey D; Herzog H Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371 [TBL] [Abstract][Full Text] [Related]
40. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]